125 related articles for article (PubMed ID: 188429)
1. [Systemic effect of diflucortolone valerate after dermal application (author's transl)].
Wendt H; Reckers R
Arzneimittelforschung; 1976; 26(7b):1509-13. PubMed ID: 188429
[TBL] [Abstract][Full Text] [Related]
2. [Studies on the Pharmacology of 6alpha,9-difluoro-11beta-hydroxy-16alpha-methyl-21-valeryloxy-1,4-pregnadiene-3,20-dione (diflucortolon valerate) (author's transl)].
Kapp VJ; Koch H; Casals-Stenzel J; Töpert M; Gerhards E
Arzneimittelforschung; 1976; 26(7b):1463-75. PubMed ID: 188428
[TBL] [Abstract][Full Text] [Related]
3. [Toxicological examination of pure diflucortolone valerate and its formulations as ointment, fatty ointment and cream in animal experiments (author's transl)].
Günzel VP; Etreby MF; Bhargava AS; Poggel HA; Schöbel C; Schuppler J; Siegmund F; Staben P
Arzneimittelforschung; 1976; 26(7b):1476-9. PubMed ID: 1036942
[TBL] [Abstract][Full Text] [Related]
4. [Multicentre-clinical trial of the novel corticosteroid diflucortolone valerate in the forms of cream, ointment and fatty ointment. Part I: Comparative study of diflucortolone valerate with fluocortolone, -capronate, -pivalate in a double-blind contralateral design with topical application (author's transl)].
Reckers VR; Wendt H
Arzneimittelforschung; 1976; 26(7b):1499-504. PubMed ID: 795433
[TBL] [Abstract][Full Text] [Related]
5. [Multicentre-clinical trial of the novel corticosteroid diflucortolone valerate in the forms of cream, ointment and fatty ointment. Part II: Comparative study with several commercial preparations (author's transl)].
Reckers VR; Wendt H
Arzneimittelforschung; 1976; 26(7b):1504-9. PubMed ID: 795434
[TBL] [Abstract][Full Text] [Related]
6. [Efficacy of diflucortolone valerate in the vasoconstriction tests].
Wendt VH; Reckers R
Arzneimittelforschung; 1976; 26(7b):1495-8. PubMed ID: 1036946
[TBL] [Abstract][Full Text] [Related]
7. [Percutaneous absorption of diflucortolone valerate in guinea pigs and man (author's transl)].
Täuber VU
Arzneimittelforschung; 1976; 26(7b):1479-84. PubMed ID: 1036943
[TBL] [Abstract][Full Text] [Related]
8. [Comparative studies in man on the percutaneous absorption of diflucortolone valerate, betamethasone-17-valerate, beclomethasone dipropionate and fluocinolone acetonide].
Täuber VU; Amin M; Fuchs P; Speck U
Arzneimittelforschung; 1976; 26(7b):1492-5. PubMed ID: 1036945
[TBL] [Abstract][Full Text] [Related]
9. [Pharmacokinetics and biotransformation of diflucortolone valerate in man (author's transl)].
Mützel VW
Arzneimittelforschung; 1976; 26(7b):1487-92. PubMed ID: 1036944
[TBL] [Abstract][Full Text] [Related]
10. [The effect of fluocortin butylester on adrenal function in man (author's transl)].
Wendt H
Arzneimittelforschung; 1977; 27(11a):2236-8. PubMed ID: 580036
[TBL] [Abstract][Full Text] [Related]
11. [Biotransformation of diflucortolone valerate in the skin of rat, guinea pig and man (author's transl)].
Täuber VU; Toda T
Arzneimittelforschung; 1976; 26(7b):1484-7. PubMed ID: 1036940
[TBL] [Abstract][Full Text] [Related]
12. Topical halcinonide and betamethasone valerate effects on plasma cortisol: acute and subacute usage studies.
Gomez EC; Kaminester L; Frost P
Arch Dermatol; 1977 Sep; 113(9):1196-202. PubMed ID: 332089
[TBL] [Abstract][Full Text] [Related]
13. [Clinico-pharmacological studies on the acne-inducing action of fluocortin butylester (author's transl)].
Wendt H
Arzneimittelforschung; 1977; 27(11a):2245-6. PubMed ID: 146498
[TBL] [Abstract][Full Text] [Related]
14. Adrenocortical suppression by topically applied corticosteroids in healthy dogs.
Zenoble RD; Kemppainen RJ
J Am Vet Med Assoc; 1987 Sep; 191(6):685-8. PubMed ID: 2824410
[TBL] [Abstract][Full Text] [Related]
15. [Clinical trial of fluocortin butylester in a double-blind contralateral comparison versus fluocortolone and hydrocortisone acetate (author's transl)].
Reckers R
Arzneimittelforschung; 1977; 27(11a):2240-4. PubMed ID: 341901
[TBL] [Abstract][Full Text] [Related]
16. Diflucortolone valerate (Nerisona): a comparative vasoconstriction test in artificially induced hyperemia of the skin.
Reckers R; Wendt H
Clin Ther; 1980; 3(3):190-3. PubMed ID: 7459929
[TBL] [Abstract][Full Text] [Related]
17. Onset of the vasoconstrictor effect of diflucortolone valerate, betamethasone valerate, and fluocinolone acetonide ointments applied for varying periods under occlusive dressings.
Szadurski J; Renz F; Gasser D
Dermatologica; 1976; 153(4):236-42. PubMed ID: 1017533
[TBL] [Abstract][Full Text] [Related]
18. [Results of a multi-center, international clinical trial of difluocortolone valerate (Nerisona)].
Langen M; Hernandez MS
Z Hautkr; 1976; 51 Suppl 1():1-16. PubMed ID: 795179
[TBL] [Abstract][Full Text] [Related]
19. Effect on plasma cortisol level and urinary cortisol excretion, in healthy volunteers, after application of three different topical steroid ointments under occlusion.
Scott M; Malmsten LA; Thelin I
Acta Derm Venereol; 1981; 61(6):543-6. PubMed ID: 6177167
[TBL] [Abstract][Full Text] [Related]
20. [Effect of fluocortin butylester (0.75%) as an ointment in the pyrexal erythema test on human skin (author's transl)].
Heite HJ; Etspüler J
Arzneimittelforschung; 1977; 27(11a):2234-5. PubMed ID: 580035
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
